High-dose antithrombin III in the treatment of severe sepsis in patients with a high risk of death: Efficacy and safety*

Abstract

Treatment with high-dose antithrombin III may increase survival time up to 90 days in patients with severe sepsis and high risk of death. This benefit may even be stronger when concomitant heparin is avoided.